NCT04888676

Brief Summary

This study will be conducted to evaluate and compare the clinical performance of Self- Adhesive Bulk fill Resin Composite Versus Conventionally Bonded Bulk fill resin composite in Restoration of Proximal Lesions Over a Period of 18 months Follow-up Examination and selection of all patients will be done according to inclusion and exclusion criteria.A Class II cavity will be prepared after local anesthesia has been given as required. Sectional matricing and wedging will be done. Followed by, placement of restorative material according to the randomization sequence,. For the intervention: The sectional matrix will be applied first , followed by filling of cavity with Advanced Self- Adhesive bulk-fill Resin Composite. (Surefil one™ ,Dentsupply Sirona) in increments of 3-4mm,For the control group: The sectional matrix will be applied first , followed by filling of cavity with bulk-fill resin composite material (GrandioSO x-tra® bulk) in increments of 3-4mm,Clinical evaluation will be done using using USPHS criteria at 6,12 and 18 months follow up.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 6, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 17, 2021

Completed
29 days until next milestone

Study Start

First participant enrolled

June 15, 2021

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2023

Completed
Last Updated

October 18, 2022

Status Verified

October 1, 2022

Enrollment Period

1.5 years

First QC Date

May 6, 2021

Last Update Submit

October 17, 2022

Conditions

Outcome Measures

Primary Outcomes (5)

  • Fracture

    The restoration will be clinically assessed using USPHS criteria. Restorations will be given the score Alpha for the ideal clinical situation, Bravo for clinically acceptable and Charlie for clinically unacceptable and in need for replacement.

    18 months

  • Marginal adaptation

    The restoration will be clinically assessed using USPHS criteria. Restorations will be given the score Alpha for the ideal clinical situation, Bravo for clinically acceptable and Charlie for clinically unacceptable and in need for replacement.

    18 months

  • Anatomic form

    The restoration will be clinically assessed using USPHS criteria. Restorations will be given the score Alpha for the ideal clinical situation, Bravo for clinically acceptable and Charlie for clinically unacceptable and in need for replacement.

    18 months

  • Surface roughness

    The restoration will be clinically assessed using USPHS criteria. Restorations will be given the score Alpha for the ideal clinical situation, Bravo for clinically acceptable and Charlie for clinically unacceptable and in need for replacement.

    18 months

  • Retention

    The restoration will be clinically assessed using USPHS criteria. Restorations will be given the score Alpha for the ideal clinical situation, Bravo for clinically acceptable and Charlie for clinically unacceptable and in need for replacement.

    18 months

Secondary Outcomes (2)

  • Postoperative sensitivity

    18 months

  • secondary caries

    18 months

Study Arms (2)

Self- Adhesive Bulk fill Resin Composite ( Surefil one™ ,Dentsupply Sirona)

EXPERIMENTAL

New Surefil one™ restorative Self-adhesive: no etching, bonding or cavity conditioning inserted in increments of up to 4 mm in thickness.

Procedure: Class II Restoration

Bulkfill Resin Composite. (Tetric N-Ceram Bulk Fill )

ACTIVE COMPARATOR

after selective etching of enamel and bonding, the bulk-fill composite resins are inserted in increments of up to 4 mm in thickness.

Procedure: Class II Restoration

Interventions

A Class II cavity will be prepared after local anesthesia has been given as required.Rubber dam isolation will be done.Sectional matricing and wedging will be done. Followed by, placement of restorative material according to the randomization sequence.followed by filling of cavity in increments of 3-4mm

Bulkfill Resin Composite. (Tetric N-Ceram Bulk Fill )Self- Adhesive Bulk fill Resin Composite ( Surefil one™ ,Dentsupply Sirona)

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient-related criteria:
  • Patients consulting in one of the outpatient clinics listed above.
  • Able to tolerate necessary restorative procedures.
  • Provide informed consent.
  • Accepts the 18 months follow-up period.
  • Tooth related criteria:
  • Teeth with primary proximal carious lesions .
  • Teeth are vital according to pulp-sensitivity tests.

You may not qualify if:

  • Patient-related criteria:
  • Medically compromised patients, as they will not be able to attend multiple appointments or may require special management.
  • Pregnant women; as radiographs cannot be taken for them.
  • Allergy to any of the restorative materials, including anesthetics.
  • Uncooperative patients, will not abide by the instructions or attend the appointments.
  • Tooth related criteria:
  • Deciduous teeth; as the study is targeting only permanent teeth.
  • Teeth with previous restorations, which may add another variable to the study (type of old restorative material, extent of recurrent caries).
  • Spontaneous pain or prolonged pain after sensitivity tests (cold and electrical tests), which would indicate irreversible pulpal damage.
  • Negative sensitivity tests, periapical radiolucencies and sensitivity to axial or lateral percussion, which would indicate pulp necrosis.
  • Teeth presenting external or internal resorption, with adverse pulpal reactions which may affect the outcome of the study.
  • Teeth with cervical caries; which can't be evaluated on periapical radiographs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mohamed Mohamed sabry Mohamed

Cairo, Nasr City, 11311, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The participants Participants will be blinded to the technique used, since the patient will attend the same number of visits and he can not differentiate between different restorative materials. Blinding of the operator The operator cannot be blinded because of the use of different restorative materials applied in each group. The outcome assessor The outcome assessor will be blinded to the material used. This will be performed by M.A. and Y.H. Therefore it is necessary that the assessors won't be included in the preclinical assessment.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized Parallel Controlled Trial. Trial type: Two, Parallel arm design. Trial framework: Equivalence frame Allocation ratio: 1:1.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Assistant lecturer at Conservative department.

Study Record Dates

First Submitted

May 6, 2021

First Posted

May 17, 2021

Study Start

June 15, 2021

Primary Completion

December 15, 2022

Study Completion

May 15, 2023

Last Updated

October 18, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will share

* Full protocol will be published online in Clinicaltrials.gov to avoid repetition, and keep the integrity of the research work. * Thesis will be discussed and defended in front of a judgment committee. * The study will be published to report the results of this clinical trial.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
24 months
Access Criteria
open access

Locations